Elicio Therapeutics Statistics

Total Valuation

ELTX has a market cap or net worth of $102.52 million. The enterprise value is $96.67 million.

Market Cap	102.52M
Enterprise Value	96.67M

Important Dates

The last earnings date was Wednesday, May 15, 2024, after market close.

Earnings Date	May 15, 2024
Ex-Dividend Date	n/a

Share Statistics

ELTX has 10.23 million shares outstanding. The number of shares has increased by 3,069.93% in one year.

Shares Outstanding	10.23M
Shares Change (YoY)	+3,069.93%
Shares Change (QoQ)	+103.19%
Owned by Insiders (%)	29.51%
Owned by Institutions (%)	4.04%
Float	5.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	21.05
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.37, with a Debt / Equity ratio of 1.37.

Current Ratio	2.37
Quick Ratio	n/a
Debt / Equity	1.37
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-50.78

Financial Efficiency

Return on equity (ROE) is -293.80% and return on invested capital (ROIC) is -330.80%.

Return on Equity (ROE)	-293.80%
Return on Assets (ROA)	-129.70%
Return on Capital (ROIC)	-330.80%
Revenue Per Employee	n/a
Profits Per Employee	-$1.22M
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.56% in the last 52 weeks.

Beta (1Y)	n/a
52-Week Price Change	+22.56%
50-Day Moving Average	8.19
200-Day Moving Average	7.03
Relative Strength Index (RSI)	60.57
Average Volume (30 Days)	58,066

Short Selling Information

The latest short interest is 85,362, so 0.83% of the outstanding shares have been sold short.

Short Interest	85,362
Short Previous Month	61,907
Short % of Shares Out	0.83%
Short % of Float	1.58%
Short Ratio (days to cover)	1.45

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-38.18M
Pretax Income	-38.99M
Net Income	-38.99M
EBITDA	-36.83M
EBIT	-38.24M
Earnings Per Share (EPS)	-$8.63

Full Income Statement

Balance Sheet

The company has $12.52 million in cash and $6.67 million in debt, giving a net cash position of $5.85 million or $0.57 per share.

Cash & Cash Equivalents	12.52M
Total Debt	6.67M
Net Cash	5.85M
Net Cash Per Share	$0.57
Equity / Book Value	4.87M
Book Value Per Share	0.48
Working Capital	8.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$36.74 million and capital expenditures -$29,000, giving a free cash flow of -$36.77 million.

Operating Cash Flow	-36.74M
Capital Expenditures	-29,000
Free Cash Flow	-36.77M
FCF Per Share	-$3.58

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ELTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3,069.93%
Shareholder Yield	-3,069.93%
Earnings Yield	-38.03%
FCF Yield	-35.86%

Analyst Forecast

The average price target for ELTX is $10.00, which is -0.50% lower than the current price. The consensus rating is "Buy".

Price Target	$10.00
Price Target Difference	-0.50%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on June 2, 2023. It was a reverse split with a ratio of 1:10.

Last Split Date	Jun 2, 2023
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1